• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

About FDA

  • Print
  • Share
  • E-mail
-

FDA-TRACK Active

The list below provides information on FDA's performance measures and projects as aligned to FDA strategic priorities and program offices. This list enables you to view charts of performance data and progress on important projects and programs.

To view completed FDA-TRACK performance measures and projects view the Archive Index

Filter






Results

Number of results:8

 ItemProgramOfficeStrategic PlanStrategic Goal/Area
1 Number of electronic patient records (from national and international clinical registries, claims data, and EHRs) with device identification that CDRH gained access to CDRH All CDRH Strategic Plan Establish a National Evaluation System for Medical Devices
2 Percentage increase of the number of premarket and postmarket regulatory decisions that leverage real-world evidence (compared to FY2015 baseline) CDRH All CDRH Strategic Plan Establish a National Evaluation System for Medical Devices
3 Number of patient groups that participated in a mechanism for CDRH employees to obtain patient input on key pre- and postmarket issues CDRH All CDRH Strategic Plan Partner with Patients
4 Percentage of CDRH employees that interact with patients as part of their job duties CDRH All CDRH Strategic Plan Partner with Patients
5 Percentage of PMA, de novo and HDE decisions that includes a public summary of available and relevant patient perspective data considered CDRH All CDRH Strategic Plan Partner with Patients
6 Number of patient perspective studies (e.g., evaluating patient reported outcomes (PRO) or patient preferences (PPI)) used in support of premarket and postmarket regulatory decisions (compared to FY 2015 baseline) CDRH All CDRH Strategic Plan Partner with Patients
7 Percent increase of the number of CDRH staff with quality and process improvement credentials to improve organizational excellence (compared to FY 2015 baseline) CDRH All CDRH Strategic Plan Promote a Culture of Quality and Organizational Excellence
8 Strengthen Product and Manufacturing Quality within the Medical Device Ecosystem Milestones CDRH All CDRH Strategic Plan Promote a Culture of Quality and Organizational Excellence

Note: The data provided on this website is produced on an ongoing basis for performance management purposes and is subject to change due to updates of preliminary estimates, corrections, or other reasons. In addition, FDA may change the type or amount of data provided on this website at any time. Information in the Archive Index may include measures and/or key projects for which activities are ongoing but no longer tracked as part of FDA-TRACK.


-
-